ESPR vs IT · rev $332.3M vs P/E 16, rev $6.27B
Esperion Therapeutics Inc (ESPR) versus Gartner Inc (IT) — a side-by-side from cached financials, not a winner call.
Esperion Therapeutics Inc (ESPR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Gartner Inc (IT) is a information technology services company listed on US.
Latest reported ESPR revenue for 2024-12-31 was $332.3M. Net income was -$51.7M. Revenue was up 185.7% from 2023-12-31 to 2024-12-31. ESPR currently screens at market cap $816.9M.
Latest reported IT revenue for 2024-12-31 was $6.27B. Net income was $1.25B. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. IT currently screens at market cap $11.03B and trailing P/E 16.3.
ESPR currently screens at market cap $816.9M. IT currently screens at market cap $11.03B and trailing P/E 16.3.
Not investment advice. Open the ESPR and IT stock pages for the full models.
Not investment advice.